Drugs / etazolate
etazolate
also known as
EHT 0202 · Etazolate hcl · ETAZOLATE HYDROCHLORIDE · Etazolato · NSC-163611 · SO 20009 · SQ 20009
Small molecule targets GABRB3 via activation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00880412 | Apr 2008 → Jun 2009 | Alzheimer disease | Exonhit | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | etazolate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00880412 ↗ |
| Known as | EHT 0202 | “EHT 0202 etazolate” NCT00880412 ↗ |
| Known as | Etazolate hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL356388 ↗ |
| Known as | ETAZOLATE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL356388 ↗ |
| Known as | Etazolato | ChEMBL registry synonym — accepted as the source's own label CHEMBL356388 ↗ |
| Known as | NSC-163611 | ChEMBL registry synonym — accepted as the source's own label CHEMBL356388 ↗ |
| Known as | SO 20009 | ChEMBL registry synonym — accepted as the source's own label CHEMBL356388 ↗ |
| Known as | SQ 20009 | ChEMBL registry synonym — accepted as the source's own label CHEMBL356388 ↗ |
| Action | Activate | “GABA receptor beta-3 subunit positive allosteric modulator” CHEMBL356388 ↗ |
| Modality | Small molecule | — CHEMBL356388 ↗ |
| Target | GABRB3 | “GABA receptor beta-3 subunit positive allosteric modulator” CHEMBL356388 ↗ |